Luca’s CoughSearch® Debuts on Ant Group’s AQ Platform at Bund 2025 -Redefining Respiratory Diagnostics with AI

Shanghai, China September 13, 2025 – Luca Healthcare unveiled its flagship respiratory diagnostic tool, CoughSearch®, at the Inclusion-Bund Conference hosted by Ant Group. As one of the world’s most influential technology events, the Bund Conference highlights cutting-edge digital innovations driving transformation across AI and digital health.

At the Future Health Pavilion, Luca unveiled its breakthrough product – CoughSearch®, an AI-powered diagnostic tool that analyzes cough sounds to detect pulmonary diseases. As an ecosystem partner of Ant Health’s AQ medical AI platform, CoughSearch® drew significant attention from attendees, media, and healthcare experts.

This year’s conference, themed “Inclusion,” featured over 10,000 square meters of exhibition space, covering AGI, robotics, future health, and intelligent payments. The Future Health Pavilion showcased Ant Health’s latest AI applications in disease screening, health management, and medical services through interactive experiences.

The CoughSearch® demo allowed users to generate a diagnostic report in under one minute using just 3–5 voluntary cough sounds. Over the four-day event, the technology became a standout attraction, with visitors lining up to assess their coughs. After receiving their diagnostic reports, users could engage with AQ for personalized interpretation and health guidance.

The integration of AQ’s medical language model with Luca’s digital biomarker technology is shaping the next generation of AI-powered healthcare. “Cough sounds are bio “signatures” that hold the potential to help solve a global respiratory crisis that impacts 750 million people with chronic respiratory diseases and over 1 billion new patients with acute infections annually”, said Dr. Echo Chen, CEO of Luca Healthcare.

Looking ahead, users will be able to assess their respiratory health in real time via CoughSearch®, and seamlessly access follow-up services such as symptom checking, report analysis, and online appointments, all powered by AQ. AI is no longer just a tool, it’s becoming a 24/7 intelligent health companion.

Luca Healthcare remains committed to advancing digital respiratory medicine. Through innovative, clinically-validated technologies and strategic partnerships, Luca continues to drive the real-world adoption of AI healthcare for all.